Tilli TM - Search Results

1

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.

de Brito E Cunha D, Frederico ABT, Azamor T, Melgaço JG, da Costa Neves PC, Bom APDA, Tilli TM, Missailidis S. de Brito E Cunha D, et al. Among authors: tilli tm. Pharmaceuticals (Basel). 2022 May 5;15(5):575. doi: 10.3390/ph15050575. Pharmaceuticals (Basel). 2022. PMID: 35631401 Free PMC article. Review.

2

Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making.

Tilli TM. Tilli TM. J Pers Med. 2021 Dec 10;11(12):1348. doi: 10.3390/jpm11121348. J Pers Med. 2021. PMID: 34945820 Free PMC article. Review.

3

Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.

Tilli TM, Carels N, Tuszynski JA, Pasdar M. Tilli TM, et al. Oncotarget. 2016 Sep 27;7(39):63189-63203. doi: 10.18632/oncotarget.11055. Oncotarget. 2016. PMID: 27527857 Free PMC article.

4

Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.

Tilli TM, Mello KD, Ferreira LB, Matos AR, Accioly MT, Faria PA, Bellahcène A, Castronovo V, Gimba ER. Tilli TM, et al. Prostate. 2012 Nov;72(15):1688-99. doi: 10.1002/pros.22523. Epub 2012 Apr 11. Prostate. 2012. PMID: 22495819 Free article.

5

A computational strategy to select optimized protein targets for drug development toward the control of cancer diseases.

Carels N, Tilli T, Tuszynski JA. Carels N, et al. PLoS One. 2015 Jan 27;10(1):e0115054. doi: 10.1371/journal.pone.0115054. eCollection 2015. PLoS One. 2015. PMID: 25625699 Free PMC article.

6

Toward precision medicine of breast cancer.

Carels N, Spinassé LB, Tilli TM, Tuszynski JA. Carels N, et al. Among authors: tilli tm. Theor Biol Med Model. 2016 Feb 29;13:7. doi: 10.1186/s12976-016-0035-4. Theor Biol Med Model. 2016. PMID: 26925829 Free PMC article. Review.

7

Chemical synthesis, pharmacological evaluation and in silico analysis of new 2,3,3a,4,5,6-hexahydrocyclopenta[c]pyrazole derivatives as potential anti-mitotic agents.

Minu M, Singh D, Mahaddalkar T, Lopus M, Winter P, Ayoub AT, Missiaen K, Tilli TM, Pasdar M, Tuszynski J. Minu M, et al. Among authors: tilli tm. Bioorg Med Chem Lett. 2016 Aug 15;26(16):3855-61. doi: 10.1016/j.bmcl.2016.07.025. Epub 2016 Jul 9. Bioorg Med Chem Lett. 2016. PMID: 27449957

8

A strategy to identify housekeeping genes suitable for analysis in breast cancer diseases.

Tilli TM, Castro Cda S, Tuszynski JA, Carels N. Tilli TM, et al. BMC Genomics. 2016 Aug 15;17(1):639. doi: 10.1186/s12864-016-2946-1. BMC Genomics. 2016. PMID: 27526934 Free PMC article.

9

Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like Mechanism.

Ayoub AT, Abou El-Magd RM, Xiao J, Lewis CW, Tilli TM, Arakawa K, Nindita Y, Chan G, Sun L, Glover M, Klobukowski M, Tuszynski J. Ayoub AT, et al. Among authors: tilli tm. J Med Chem. 2016 Oct 27;59(20):9532-9540. doi: 10.1021/acs.jmedchem.6b01264. Epub 2016 Oct 18. J Med Chem. 2016. PMID: 27718573

10

Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer.

Tuszynski J, Tilli TM, Levin M. Tuszynski J, et al. Among authors: tilli tm. Curr Pharm Des. 2017;23(32):4827-4841. doi: 10.2174/1381612823666170530105837. Curr Pharm Des. 2017. PMID: 28554310 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page